These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 12121906)

  • 1. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.
    Biron KK; Harvey RJ; Chamberlain SC; Good SS; Smith AA; Davis MG; Talarico CL; Miller WH; Ferris R; Dornsife RE; Stanat SC; Drach JC; Townsend LB; Koszalka GW
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2365-72. PubMed ID: 12121906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus.
    Evers DL; Komazin G; Shin D; Hwang DD; Townsend LB; Drach JC
    Antiviral Res; 2002 Oct; 56(1):61-72. PubMed ID: 12323400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.
    Zacny VL; Gershburg E; Davis MG; Biron KK; Pagano JS
    J Virol; 1999 Sep; 73(9):7271-7. PubMed ID: 10438815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.
    McSharry JJ; McDonough A; Olson B; Talarico C; Davis M; Biron KK
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1279-81. PubMed ID: 11687477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.
    Evers DL; Komazin G; Ptak RG; Shin D; Emmer BT; Townsend LB; Drach JC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3918-27. PubMed ID: 15388453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
    Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.
    Komazin G; Ptak RG; Emmer BT; Townsend LB; Drach JC
    J Virol; 2003 Nov; 77(21):11499-506. PubMed ID: 14557635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product.
    Underwood MR; Harvey RJ; Stanat SC; Hemphill ML; Miller T; Drach JC; Townsend LB; Biron KK
    J Virol; 1998 Jan; 72(1):717-25. PubMed ID: 9420278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus.
    Krosky PM; Borysko KZ; Nassiri MR; Devivar RV; Ptak RG; Davis MG; Biron KK; Townsend LB; Drach JC
    Antimicrob Agents Chemother; 2002 Feb; 46(2):478-86. PubMed ID: 11796361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).
    Chan JH; Chamberlain SD; Biron KK; Davis MG; Harvey RJ; Selleseth DW; Dornsife RE; Dark EH; Frick LW; Townsend LB; Drach JC; Koszalka GW
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):101-23. PubMed ID: 10772705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus.
    Underwood MR; Ferris RG; Selleseth DW; Davis MG; Drach JC; Townsend LB; Biron KK; Boyd FL
    Antimicrob Agents Chemother; 2004 May; 48(5):1647-51. PubMed ID: 15105116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.
    Selleseth DW; Talarico CL; Miller T; Lutz MW; Biron KK; Harvey RJ
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1468-71. PubMed ID: 12654696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56.
    Krosky PM; Underwood MR; Turk SR; Feng KW; Jain RK; Ptak RG; Westerman AC; Biron KK; Townsend LB; Drach JC
    J Virol; 1998 Jun; 72(6):4721-8. PubMed ID: 9573236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides.
    Komazin G; Townsend LB; Drach JC
    J Virol; 2004 Jan; 78(2):710-5. PubMed ID: 14694102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
    Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
    O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
    Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.
    McGregor A; Choi KY; Cui X; McVoy MA; Schleiss MR
    Antiviral Res; 2008 Jun; 78(3):250-9. PubMed ID: 18325607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.
    Gershburg E; Pagano JS
    J Virol; 2002 Feb; 76(3):998-1003. PubMed ID: 11773375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells.
    Nassiri MR; Emerson SG; Devivar RV; Townsend LB; Drach JC; Taichman RS
    Br J Haematol; 1996 May; 93(2):273-9. PubMed ID: 8639416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole riboside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus genome maturation.
    McVoy MA; Nixon DE
    J Virol; 2005 Sep; 79(17):11115-27. PubMed ID: 16103162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.